SEC Form 4 · accession 0001103780-15-000002

Lexaria Bioscience Corp. · LXRP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President · Director · 10% Owner

Period of report

Jan 20, 2010

Accepted (ET)

Jan 15, 2015 · 6:05 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001348362

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Shares	Jan 14, 2015	P	26,100	$0.10	A	6,207,936	D
Common Shares	Jan 14, 2015	P	23,900	$0.10	A	6,231,836	D
Common Shares	Jan 15, 2015	P	2,633	$0.095	A	6,234,469	D
Common Shares	Jan 15, 2015	P	27,367	$0.095	A	6,261,836	D
Common Shares	Jan 15, 2015	P	30,000	$0.095	A	6,291,836	D
Common Shares	Jan 15, 2015	P	29,000	$0.09	A	6,320,836	D
Common Shares	Jan 15, 2015	P	40,000	$0.099	A	6,360,836	D
Common Shares	Jan 15, 2015	P	10,000	$0.099	A	6,370,836	D
Common Shares	holding	—	—		—	1,488,561	D
Common Shares	holding	—	—		—	3,219,586	I	Private Holding Company
Common Shares	holding	—	—		—	4,881,819	D
Common Shares	holding	—	—		—	5,907,836	I	Private Holding Company
Common Shares	holding	—	—		—	6,181,836	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options	$0.20	holding	—	—	—	Jan 20, 2011	Jan 20, 2015	Common Shares	500,000	500,000	D
Stock Options	$0.35	holding	—	—	—	Jul 11, 2011	Jul 11, 2016	Common Shares	200,000	700,000	D
Stock Options	$0.10	holding	—	—	—	Jun 18, 2013	Jun 18, 2018	Common Shares	225,000	925,000	D
Warrants	$0.25	holding	—	—	—	Mar 21, 2014	Sep 21, 2015	Common Shares	100,067	1,025,067	D